semaglutide tablets alternative A new tablet version of the weight loss drug Wegovy has launched in the UK, with pharmacies expecting demand to rise sharply. Unlike existing injectable weight loss medications, the new Wegovy tablet Cheaper obesity medications could come

[1] Wegovy follows a more gradual escalation schedule over 1620 weeks: Weeks 14 : 0.25 mg once weekly Weeks 58 : 0.5 mg once weekly Weeks 912 : 1 mg once weekly Weeks 1316 : 1.7 mg once weekly Week 17 onward : 2.4 mg once weekly (maintenance dose) If patients do not tolerate a dose during titration, the prescribing information allows for delaying dose escalation for additional weeks

40% of participants lost 20% of their body weight after 20 weeks

Semaglutide targets the GLP-1 receptor, whereas tirzepatide activates both GLP-1 and GIP receptors

If youre searching for this comparison, its worth knowing that Saxenda has been discontinued by Novo Nordisk

This happens frequently in telehealth environments where the prescribing provider and the dispensing pharmacy are separate entities